A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics

Neurodegenerative disorders are primarily characterized by neuron loss. This review briefly describes the pathophysiology of Alzheimer's, Parkinson's disease, and amyotrophic lateral sclerosis, and their current management approaches.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 The most common neurodegenerative disorders include Alzheimer's and Parkinson's disease.
• 2 Although there are several medicines currently approved for managing neurodegenerative disorders, a large majority of them only help with associated symptoms.
• 3 This lack of pathogenesis-targeting therapies is primarily due to the restrictive effects of the blood-brain barrier (BBB), which keeps close to 99% of all "foreign substances" out of the brain.

These innovations can translate to real-world improvements in technology, infrastructure, and everyday tools.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: